Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

SELL
$103.24 - $121.81 $216,391 - $255,313
-2,096 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$93.1 - $112.54 $42,360 - $51,205
-455 Reduced 17.84%
2,096 $233,000
Q4 2021

Feb 07, 2022

SELL
$95.88 - $117.08 $29,531 - $36,060
-308 Reduced 10.77%
2,551 $286,000
Q3 2021

Nov 09, 2021

SELL
$84.42 - $106.62 $125,785 - $158,863
-1,490 Reduced 34.26%
2,859 $274,000
Q2 2021

Aug 11, 2021

BUY
$67.66 - $84.76 $30,176 - $37,802
446 Added 11.43%
4,349 $364,000
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $261,735 - $295,925
3,903 New
3,903 $263,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.